Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MOMENTA PHARMACEUTICALS INCMNTA · Entity 146313 | Senior VP, Development and Chi | November 21, 2016 | November 23, 2016 |
| Pulmatrix, Inc.PULM · Entity 8249 | Chief Medical Officer | June 05, 2018 | June 06, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MOMENTA PHARMACEUTICALS INC
Report date November 21, 2016 · Filed November 23, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 155,381 |
Ending reported balance
After 2016-11-22 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2016-11-21 · Sale · Disposed 416 · Balance 156,056 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2009. Row 2 · 2016-11-21 · Sale · Disposed 425 · Balance 155,631 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2009. Row 3 · 2016-11-22 · Sale · Disposed 250 · Balance 155,381 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2009. |
Filing footnotes · ownership attribution and instrument terms
F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2009.
Pulmatrix, Inc.
Report date June 05, 2018 · Filed June 06, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.47 · Expires 2028-06-05 | Direct | 801,000 |
Reported balance
After 2018-06-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-06-05 · Grant · Acquired 801,000 · Balance 801,000 F1: One-fourth (1/4) of the option vested on June 5, 2018 and the remainder vests in thirty-six (36) equal monthly installments with 2.083% vesting on the last day of each of the next thirty-six (36) months that follow June 5, 2018, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. 2013 Employee, Director and Consultant Equity Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: One-fourth (1/4) of the option vested on June 5, 2018 and the remainder vests in thirty-six (36) equal monthly installments with 2.083% vesting on the last day of each of the next thirty-six (36) months that follow June 5, 2018, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. 2013 Employee, Director and Consultant Equity Incentive Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2018 Filed Jun 6, 2018 18:05 UTC | Pulmatrix, Inc. PULM · Entity 8249 | GrantStock Option (Right to Buy) · Derivative | 801,000 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0000899243-18-015306 · doc4.xml · derivative · entry 1 Roach James M. · CIK 0001427944 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 801,000 Underlying: Common Stock · 801,000 shares Expires 2028-06-05 F1 · derivative.exercise_date: One-fourth (1/4) of the option vested on June 5, 2018 and the remainder vests in thirty-six (36) equal monthly installments with 2.083% vesting on the last day of each of the next thirty-six (36) months that follow June 5, 2018, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. 2013 Employee, Director and Consultant Equity Incentive Plan. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:18 UTC | Pulmatrix, Inc. PULM · Entity 8249 | GrantStock Option (Right to Buy) · Derivative | 360,000 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0000899243-17-025524 · doc4.xml · derivative · entry 1 Roach James M. · CIK 0001427944 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Stock · 360,000 shares Expires 2027-11-03 F1 · derivative.exercise_date: One-fourth (1/4) of the option vests on November 3, 2018 and the remainder vests in thirty-six (36) equal monthly installments with 2.083% vesting on the last day of each of the next thirty-six (36) months that follow November 3, 2018, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. 2013 Employee, Director and Consultant Equity Incentive Plan. Read SEC document |
| November 22, 2016 Filed Nov 23, 2016 10:41 UTC | MOMENTA PHARMACEUTICALS INC MNTA · Entity 146313 | SaleCommon Stock | 250 | $14.40 | $3,600.00 |
DisclosureSEC source: 0001179110-16-031999 · edgar.xml · nonDerivative · entry 3 Roach James M. · CIK 0001427944 · Senior VP, Development and Chi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,381 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2009. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 10:41 UTC | MOMENTA PHARMACEUTICALS INC MNTA · Entity 146313 | SaleCommon Stock | 425 | $13.45 | $5,716.25 |
DisclosureSEC source: 0001179110-16-031999 · edgar.xml · nonDerivative · entry 2 Roach James M. · CIK 0001427944 · Senior VP, Development and Chi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,631 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2009. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 10:41 UTC | MOMENTA PHARMACEUTICALS INC MNTA · Entity 146313 | SaleCommon Stock | 416 | $13.45 | $5,595.20 |
DisclosureSEC source: 0001179110-16-031999 · edgar.xml · nonDerivative · entry 1 Roach James M. · CIK 0001427944 · Senior VP, Development and Chi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,056 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2009. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.